AEON Biopharma, Inc. SEC filings AEON
AEON Biopharma, Inc. has 361 filings in SEC EDGAR's recent list, going back to Dec 23, 2020. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Nov 3, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Other events
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 15, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Listing notice
|
Apr 3, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 9, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Shareholder vote results, Regulation FD disclosure, Other events
|
Jan 21, 2026 | Jan 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 15, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 4, 2025 | Dec 4, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 13, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2025 | Sep 8, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2025 | May 20, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 25, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 21, 2025 | Apr 19, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 8, 2025 | Apr 3, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 27, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Feb 24, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 7, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 7, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 20, 2024 | Dec 18, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 7, 2024 | Oct 7, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Other events
|
Jul 9, 2024 | Jul 9, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
May 16, 2024 | May 16, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Restatement
|
May 3, 2024 | May 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 3, 2024 | May 3, 2024 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change
|
Apr 17, 2024 | Apr 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 15, 2024 | Apr 15, 2024 |
| 8-K |
Current report
Other events
|
Mar 29, 2024 | Mar 29, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2024 | Mar 29, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 28, 2024 | Mar 24, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Regulation FD disclosure
|
Mar 19, 2024 | Mar 18, 2024 |
| 8-K |
Current report
Restatement
|
Feb 16, 2024 | Feb 14, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 19, 2023 | Oct 19, 2023 |
| 8-K |
Current report
Auditor change
|
Oct 2, 2023 | Sep 28, 2023 |
| 8-K/A | Amended current report | Aug 14, 2023 | Jul 21, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jul 27, 2023 | Jul 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 24, 2023 | Jul 24, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jul 17, 2023 | Jul 13, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jul 12, 2023 | Jul 11, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jul 5, 2023 | Jul 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 30, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jun 30, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Other events
|
Jun 28, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Other events
|
Jun 26, 2023 | Jun 26, 2023 |
| 8-K |
Current report
Other events
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Listing notice, Other events
|
Jun 15, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Other events
|
Jun 13, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Other events
|
Jun 9, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Other events
|
Jun 6, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2023 | May 23, 2023 |
| 8-K |
Current report
Material agreement
|
May 1, 2023 | Apr 27, 2023 |
| 8-K |
Current report
Restatement
|
Apr 5, 2023 | Apr 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 24, 2023 | Feb 24, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 14, 2023 | Feb 14, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Feb 10, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Other events
|
Feb 6, 2023 | Feb 6, 2023 |
| 8-K |
Current report
Material agreement
|
Jan 11, 2023 | Jan 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 27, 2022 | Dec 27, 2022 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 13, 2022 | Dec 12, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 22, 2022 | Aug 19, 2022 |
| 8-K/A | Amended current report | Mar 3, 2022 | Feb 11, 2021 |
| 8-K |
Current report
Restatement
|
Feb 25, 2022 | Feb 24, 2022 |
| 8-K |
Current report
Unregistered share sale
|
Jun 29, 2021 | Jun 28, 2021 |
| 8-K |
Current report
Listing notice, Other events
|
Jun 4, 2021 | May 25, 2021 |
| 8-K |
Current report
Other events
|
Mar 26, 2021 | Mar 25, 2021 |
| 8-K/A | Amended current report | Feb 26, 2021 | Feb 11, 2021 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Feb 18, 2021 | Feb 11, 2021 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
|
Feb 12, 2021 | Feb 8, 2021 |
Showing 90 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AEON (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Aliso Viejo, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1837607
- Former names
- Priveterra Acquisition Corp. (until Jul 24, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.